Ceterix Orthopaedics, Inc. has announced it has raised $19.5 million in series B financing led by Novo Ventures.
Ceterix Orthopaedics, headquartered in Menlo Park, Calif., is a developer of surgical tools for arthroscopic procedures.
Novo Ventures, which is the holding company of the Novo Group, and is wholly owned by the Novo Nordisk Foundation, focuses on life sciences venture capital, and is active in both Europe and North America. It is a new investor in Ceterix. Joining Novo Ventures in this round of financing were existing investors Versant Ventures and 5AM Ventures.